Correlation Between Cardiol Therapeutics and Hisamitsu Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Cardiol Therapeutics and Hisamitsu Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiol Therapeutics and Hisamitsu Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiol Therapeutics Class and Hisamitsu Pharmaceutical Co, you can compare the effects of market volatilities on Cardiol Therapeutics and Hisamitsu Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiol Therapeutics with a short position of Hisamitsu Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiol Therapeutics and Hisamitsu Pharmaceutical.
Diversification Opportunities for Cardiol Therapeutics and Hisamitsu Pharmaceutical
0.17 | Correlation Coefficient |
Average diversification
The 3 months correlation between Cardiol and Hisamitsu is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cardiol Therapeutics Class and Hisamitsu Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hisamitsu Pharmaceutical and Cardiol Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiol Therapeutics Class are associated (or correlated) with Hisamitsu Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hisamitsu Pharmaceutical has no effect on the direction of Cardiol Therapeutics i.e., Cardiol Therapeutics and Hisamitsu Pharmaceutical go up and down completely randomly.
Pair Corralation between Cardiol Therapeutics and Hisamitsu Pharmaceutical
Given the investment horizon of 90 days Cardiol Therapeutics Class is expected to generate 0.11 times more return on investment than Hisamitsu Pharmaceutical. However, Cardiol Therapeutics Class is 8.83 times less risky than Hisamitsu Pharmaceutical. It trades about 0.06 of its potential returns per unit of risk. Hisamitsu Pharmaceutical Co is currently generating about -0.15 per unit of risk. If you would invest 55.00 in Cardiol Therapeutics Class on September 12, 2024 and sell it today you would earn a total of 83.00 from holding Cardiol Therapeutics Class or generate 150.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 29.29% |
| Values | Daily Returns |
Cardiol Therapeutics Class vs. Hisamitsu Pharmaceutical Co
Performance |
| Timeline |
| Cardiol Therapeutics |
| Hisamitsu Pharmaceutical |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cardiol Therapeutics and Hisamitsu Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiol Therapeutics and Hisamitsu Pharmaceutical
The main advantage of trading using opposite Cardiol Therapeutics and Hisamitsu Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiol Therapeutics position performs unexpectedly, Hisamitsu Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hisamitsu Pharmaceutical will offset losses from the drop in Hisamitsu Pharmaceutical's long position.| Cardiol Therapeutics vs. Flora Growth Corp | Cardiol Therapeutics vs. ABVC Biopharma | Cardiol Therapeutics vs. Indaptus Therapeutics | Cardiol Therapeutics vs. HCW Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |